These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 503250)

  • 1. 3H-Domperidone: a selective ligand for dopamine receptors.
    Baudry M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):231-7. PubMed ID: 503250
    [No Abstract]   [Full Text] [Related]  

  • 2. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 3H-domperidone binding on striatal dopamine receptors.
    Martres MP; Baudry M; Schwartz JC
    Life Sci; 1978 Oct; 23(17-18):1781-4. PubMed ID: 723450
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolactin-releasing effect of a novel anti-dopaminergic drug, domperidone, in the rat.
    Cocchi D; Gil-Ad I; Parenti M; Stefanini E; Locatelli V; Müller EE
    Neuroendocrinology; 1980; 30(2):65-9. PubMed ID: 7354891
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M; Totaro JA
    Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary observations on the interaction of domperidone with peripheral dopamine receptors.
    Willems JL; Bogaert MG; Buylaert W
    Jpn J Pharmacol; 1981 Feb; 31(1):131-3. PubMed ID: 7253336
    [No Abstract]   [Full Text] [Related]  

  • 7. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.
    Laduron PM; Leysen JE
    Biochem Pharmacol; 1979 Jul; 28(14):2161-5. PubMed ID: 496998
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA; Clement-Cormier Y; Lam DM
    Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 12. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors.
    Ennis C; Cox B
    J Pharm Pharmacol; 1980 Jun; 32(6):434-5. PubMed ID: 6106681
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in dopamine receptors in mouse striatum following morphine treatments.
    de la Baume S; Patey G; Marçais H; Protais P; Costentin J; Schwartz JC
    Life Sci; 1979 Jun; 24(25):2333-42. PubMed ID: 573360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.